Stay updated on Pembrolizumab for Genomic Instability Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, replacing the previously loaded study record details. This change blocks viewing core trial information, documents, and contact/location data.
    Difference
    19%
    Check dated 2026-09-21T22:12:59.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The revision entry for the Study Protocol and Statistical Analysis Plan was updated from v3.6.5 to v3.6.6, indicating a newer version of the document is now linked on the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a small maintenance update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-10T11:53:48.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page's revision line was updated to v3.6.4, indicating a software release rather than changes to study details. This appears to be a backend update without substantive changes to the trial information.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:58.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page now reflects a newer revision label (v3.6.3) replacing the previous one (v3.6.2), indicating an updated version of the study documents.
    Difference
    0.1%
    Check dated 2026-07-05T14:30:34.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Updated Study Documents section now lists the Informed Consent Form (2022-05-11) and Study Protocol/Statistical Analysis Plan (2023-02-22), and adds IPD sharing information and expanded metadata/MeSH terms.
    Difference
    59%
    Check dated 2026-06-28T08:33:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.